Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingre Huatan Tongfu Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by The First Affiliated Hospital of Guangxi Medical University. It is specifically indicated for the treatment of conscious disturbances in patients with craniocerebral injury, particularly those presenting with the TCM syndrome of 'phlegm heat and mental obstruction.' The decoction's name describes its primary therapeutic actions: 'Qingre' (clearing heat), 'Huatan' (transforming phlegm), and 'Tongfu' (unblocking the bowels). By promoting bowel movements and clearing internal heat and phlegm, the treatment aims to reduce intracranial pressure and improve neurological outcomes. In clinical settings, it is often administered via proctoclysis (rectal drip) to accommodate patients with impaired consciousness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qingre huatan tongfu decoction.